• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN, FORMERLY US SURGICAL A DIVISON POLYSORB 1 30 VIOLET HGS-21; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN, FORMERLY US SURGICAL A DIVISON POLYSORB 1 30 VIOLET HGS-21; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID Back to Search Results
Model Number CL932
Medical Device Problem Codes Break (1069); Device Or Device Fragments Location Unknown (2590)
Health Effect - Clinical Codes Radiation Exposure, Unintended (3164); Device Embedded In Tissue or Plaque (3165)
Date of Event 03/30/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).
 
Event or Problem Description
According to the reporter, during an emergency c-section procedure and while closing the first layer of uterus the surgeon, experienced that the needle was easy to pass through tissue and then after couple of throws there was a bit of resistance in passing needle through tissue.The top of the needle tip broke from its body and it couldn't be retrieve during the procedure.Surgical time was extended 30 minutes as an intraoperative x ray was taken of the patient to find the needle tip but was unsuccessful.The patient had a normal length and of stay at the hospital as required due to the nature of surgery.The patient has since been discharged from the hospital.The surgeon believes that the tip will, as a foreign body, will be encapsulated by tissue.
 
Additional Manufacturer Narrative
(b)(4).Product returned, evaluation pending.
 
Additional Manufacturer Narrative
(b)(4).Post market vigilance (pmv) led an evaluation of one suture opened by the account and four sealed sutures.A tactile and microscopic inspection of the sealed sutures was performed with no abnormalities.The visual inspection of the opened sample noted one suture segment and one needle; the needle was received with the needle tip broken.Upon microscopic inspection of the needle, instrument marks were observed at the break site.The foils were inspected with light assisted microscopy with no abnormalities.Additionally, bend moment and penetration force testing was performed on the sealed samples and the result exceeded specifications for this product.The observed instrumentation damage suggests that the needles were grasped improperly at the needle tip during application.Firmly grasping the needle at the tip weakens the needle causing it to bend and/or break.The recommended grasping area of the needle is at the needle body, where the wire is of a full diameter.Should new information become available, the file will be re-opened and the investigation summary amended as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POLYSORB 1 30 VIOLET HGS-21
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID
Manufacturer (Section D)
COVIDIEN, FORMERLY US SURGICAL A DIVISON
60 middletown ave
north haven CT 06473
MDR Report Key5603456
Report Number1219930-2016-00363
Device Sequence Number13694492
Product Code GAM
UDI-Device Identifier20884521043494
UDI-Public(01)20884521043494(17)201031(10)A5K1133WX
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K963253
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional,u
Initial Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2020
Device Model NumberCL932
Device Catalogue NumberCL932
Device Lot NumberA5K1133WX
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/06/2016
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 03/31/2016
Supplement Date Received by ManufacturerNot provided
Not provided
Initial Report FDA Received Date04/25/2016
Supplement Report FDA Received Date06/02/2016
11/20/2016
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-